US Patent Issued to Galderma Holding, Chugai Seiyaku on Oct. 7 for "Nemolizumab in the treatment of atopic dermatitis with moderate to severe excoriation" (Japanese, French Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,147, issued on Oct. 7, was assigned to Galderma Holding SA (Zug, Switzerland) and Chugai Seiyaku K.K. (Tokyo).

"Nemolizumab in the treatment of atopic dermatitis with moderate to severe excoriation" was invented by Nabil Kerrouche (Le Rouret, France), Keiko Hirokawa (Tokyo) and Ryosuke Mihara (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods for selectively treating atopic dermatitis (AD) in a subject having skin excoriations, pharmaceutical compositions for use in the treatment of atopic dermatitis in a subject having skin excoriations, uses of nemolizumab or an equivalent thereof in the manufacture of a medicament f...